Relative Expression of OX40, OX40L mRNA, and OX40L Serum Levels in Women with Recurrent Spontaneous Abortion

References

• Akiba H, Miyahira Y, Atsuta M, et al. (2000). Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis. J Exp Med, 191(2), 375–380.
   PubMed Web of Science ®Google Scholar
• Amiri Jahromi R, Nasiri M, Jahromi AR. (2017). Interferon regulatory factor 5 gene polymorphisms in iranian women with unexplained recurrent pregnancy loss. Immunol Invest, 46(1), 97–107. doi:10.1080/08820139.2016.1225759
   PubMed Web of Science ®Google Scholar
• Andersen AMN, Wohlfahrt J, Christens P, et al. (2000). Maternal age and fetal loss: population based register linkage study. Bmj, 320(7251), 1708–1712.
   PubMedGoogle Scholar
• Arestides RS, He H, Westlake RM, et al. (2002). Co-stimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation. Eur J Immunol, 32(10), 2874–2880. doi:10.1002/1521-4141(2002010)32:10<2874::AID-IMMU2874>3.0.CO;2-4
   PubMed Web of Science ®Google Scholar
• Baumann R, Yousefi S, Simon D, et al. (2004). Functional expression of CD134 by neutrophils. Eur J Immunol, 34(8), 2268–2275. doi:10.1002/eji.200324241
   PubMed Web of Science ®Google Scholar
• Burgess JK, Carlin S, Pack RA, et al. (2004). Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma? J Allergy Clin Immunol, 113(4), 683–689. doi:10.1016/j.jaci.2003.12.311
   PubMed Web of Science ®Google Scholar
• Croft M. (2010). Control of immunity by the TNFR-related molecule OX40 (CD134). Annu Rev Immunol, 28, 57–78. doi:10.1146/annurev-immunol-030409-101243
   PubMed Web of Science ®Google Scholar
• Croft M, So T, Duan W, Soroosh P. (2009). The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev, 229(1), 173–191. doi:10.1111/j.1600-065X.2009.00766.x
   PubMed Web of Science ®Google Scholar
• Dong F, Zhang Y, Xia F, et al. (2014). Genome-wide miRNA profiling of villus and decidua of recurrent spontaneous abortion patients. Reproduction, 148(1), 33–41. doi:10.1530/REP-14-0095
   PubMed Web of Science ®Google Scholar
• Ezzat MH, Imam SS, Shaheen K. (2011). Serum OX40 ligand levels in asthmatic children: a potential biomarker of severity and persistence. Allergy Asthma Proc, 32(4), 313–318. doi:10.2500/aap.2011.32.3447
   PubMed Web of Science ®Google Scholar
• Farres MN, Al-Zifzaf DS, Aly AA, Abd Raboh NM. (2011). OX40/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis. Ann Saudi Med, 31(1), 29–34. doi:10.4103/0256-4947.75775
   PubMed Web of Science ®Google Scholar
• Garrido-Gimenez C, Alijotas-Reig J. (2015). Recurrent miscarriage: causes, evaluation and management. Postgrad Med J, 91(1073), 151–162. doi:10.1136/postgradmedj-2014-132672
   PubMed Web of Science ®Google Scholar
• Hamidinia M, Ghafourian Boroujerdnia M, Talaiezadeh A, et al. (2013). Concomitant Increase of OX40 and FOXP3 transcripts in peripheral blood of patients with breast cancer. Iran J Immunol, 10(1), 22–30.
   PubMed Web of Science ®Google Scholar
• Higgins LM, McDonald SA, Whittle N, et al. (1999). Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. J Immunol, 162(1), 486–493.
   PubMed Web of Science ®Google Scholar
• Hossein H, Mahroo M, Abbas A, et al. (2004). Cytokine production by peripheral blood mononuclear cells in recurrent miscarriage. Cytokine, 28(2), 83–86. doi:10.1016/j.cyto.2004.07.002
   PubMed Web of Science ®Google Scholar
• Imura A, Hori T, Imada K, et al. (1996). The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med, 183(5), 2185–2195.
   PubMed Web of Science ®Google Scholar
• Kinnear G, Wood KJ, Fallah-Arani F, Jones ND. (2013). A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen. J Immunol, 191(3), 1465–1475. doi:10.4049/jimmunol.1300553
   PubMed Web of Science ®Google Scholar
• Krieg S, Fan X, Hong Y, et al. (2012). Global alteration in gene expression profiles of deciduas from women with idiopathic recurrent pregnancy loss. Mol Hum Reprod, 18(9), 442–450. doi:10.1093/molehr/gas017
   PubMed Web of Science ®Google Scholar
• Kwak‐Kim J, Bao S, Lee SK, et al. (2014). Immunological modes of pregnancy loss: inflammation, immune effectors, and stress. Am J Reprod Immunol, 72(2), 129–140. doi:10.1111/aji.12234
   PubMed Web of Science ®Google Scholar
• Kwiatek M, Gęca T, Krzyżanowski A, et al. (2015). Peripheral dendritic cells and CD4+CD25+Foxp3+ regulatory T cells in the first trimester of normal pregnancy and in women with recurrent miscarriage. PLoS One, 10(5), e0124747. doi:10.1371/journal.pone.0124747
   PubMed Web of Science ®Google Scholar
• Lee SK, Kim JY, Hur SE, et al. (2011). An imbalance in interleukin-17-producing T and Foxp3⁺ regulatory T cells in women with idiopathic recurrent pregnancy loss. Hum Reprod, 26(11), 2964–2971. doi:10.1093/humrep/der301
   PubMed Web of Science ®Google Scholar
• Lee SK, Kim JY, Lee M, et al. (2012). Th17 and regulatory T cells in women with recurrent pregnancy loss. Am J Reprod Immunol Apr, 67(4), 311–318. doi:10.1111/j.1600-0897.2012.01116.x
   PubMed Web of Science ®Google Scholar
• Lee SK, Na BJ, Kim JY, et al. (2013). Determination of clinical cellular immune markers in women with recurrent pregnancy loss. Am J Reprod Immunol, 70(5), 398–411. doi:10.1111/aji.12137
   PubMed Web of Science ®Google Scholar
• Li J1, Li L, Shang X, et al. (2008). Negative regulation of IL-17 production by OX40/OX40L interaction. Cell Immunol, 253(1–2), 31–37. doi:10.1016/j.cellimm.2008.04.010
   PubMed Web of Science ®Google Scholar
• Liu W, Almo SC, Zang X. (2016). Co-stimulate or co-inhibit regulatory T cells, which side to go? Immunol Invest, 45(8), 813–831. doi:10.1080/08820139.2016.1186690
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Hori T, Nishigori C, et al. (2003). Expression of CD134 and CD134 ligand in lesional and nonlesional psoriatic skin. Arch Dermatol Res, 294(12), 563–566. doi:10.1007/s00403-002-0363-6
   PubMed Web of Science ®Google Scholar
• Mei S, Tan J, Chen H, et al. (2010). Changes of CD4+ CD25 high regulatory T cells and FOXP3 expression in unexplained recurrent spontaneous abortion patients. Fertil Steril, 94(6), 2244–2247. doi:10.1016/j.fertnstert.2009.11.020
   PubMed Web of Science ®Google Scholar
• Munks MW, Mourich DV, Mittle RRS, et al. (2004). 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine. Immunology, 112(4), 559–566. doi:10.1111/j.1365-2567.2004.01910.x
   PubMed Web of Science ®Google Scholar
• Qin W, Hongya W, Yongjing C, et al. (2011). Increased OX40 and soluble OX40 ligands in children with Henoch‐Schonlein purpura: association with renal involvement. Pediatr Allergy Immunol, 22, 54–59. doi:10.1111/j.1399-3038.2010.01111.x
   PubMed Web of Science ®Google Scholar
• Rai R, Regan L. (2006). Recurrent miscarriage. The Lancet, 368(9535), 601–611. doi:10.1016/S0140-6736(06)69204-0
   PubMed Web of Science ®Google Scholar
• Rajabi P, Alaee M, Mousavizadeh K, Samadikuchaksaraei A. (2012). Altered expression of TNFSF4 and TRAF2 mRNAs in peripheral blood mononuclear cells in patients with systemic lupus erythematosus: association with atherosclerotic symptoms and lupus nephritis. Inflamm Res, 61(12), 1347–1354. doi:10.1007/s00011-012-0535-6
   PubMed Web of Science ®Google Scholar
• Redmond WL, Ruby CE, Weinberg AD. (2009). The role of OX40-mediated co-stimulation in T-cell activation and survival. Criti Rev Immunolol, 29(3), 187–201. doi:10.1615/CritRevImmunol.v29.i3.10
   PubMed Web of Science ®Google Scholar
• So T, Song J, Sugie K, et al. (2006). Signals from OX40 regulate nuclear factor of activated T cells c1 and T cell helper 2 lineage commitment. Proc Natl Acad Sci U S A, 103(10), 3740–3745. doi:10.1073/pnas.0600205103
   PubMed Web of Science ®Google Scholar
• Sonar S, Lal G. (2015). Role of tumor necrosis factor superfamily in neuroinflammation and autoimmunity. Front Immunol, 6, 364. doi:10.3389/fimmu.2015.00364
   PubMed Web of Science ®Google Scholar
• Szypowska A, Stelmaszczyk-Emmel A, Demkow U, Łuczyński W. (2014). High expression of OX40 (CD134) and 4-1BB (CD137) molecules on CD4+ CD25 high cells in children with type 1 diabetes. Adv Med Sci, 59(1), 39–43. doi:10.1016/j.advms.2013.07.003
   PubMed Web of Science ®Google Scholar
• Tsukada N, Akiba H, Kobata T, et al. (2000). Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation. Blood, 95(7), 2434–2439.
   PubMed Web of Science ®Google Scholar
• Tuladhar R, Oghumu S, Dong R, et al. (2015). Ox40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major. Exp Parasitol, 148, 49–55. doi:10.1016/j.exppara.2014.11.002
   PubMed Web of Science ®Google Scholar
• Valzasina B, Guiducci C, Dislich H, et al. (2005). Triggering of OX40 (CD134) on CD4+ CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. Blood, 105(7), 2845–2851. doi:10.1182/blood-2004-07-2959
   PubMed Web of Science ®Google Scholar
• Wang Q, Chen Y, Xie F, et al. (2006). Development of a sandwich ELISA for evaluating soluble OX40L (CD252) in human sera of different ages or with Graves’ disease. Cytokine, 36(1–2), 23–28. doi:10.1016/j.cyto.2006.10.006
   PubMed Web of Science ®Google Scholar
• Wang Y, Fu Y, Zhu Z, et al. (2012). OX40 mRNA in peripheral blood as a biomarker of acute renal allograft rejection. Chin Med J, 125(21), 3786–3790.
   PubMed Web of Science ®Google Scholar
• Watts TH. (2005). TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol, 23, 23–68. doi:10.1146/annurev.immunol.23.021704.115839
   PubMed Web of Science ®Google Scholar
• Webb GJ, Hirschfield GM, Lane PJ. (2016). OX40, OX40L and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol, 50(3), 312–332. doi:10.1007/s12016-015-8498-3
   PubMed Web of Science ®Google Scholar
• Weinberg AD, Wegmann KW, Funatake C, Whitham RH. (1999). Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis. J Immunol, 162(3), 1818–1826.
   PubMed Web of Science ®Google Scholar
• Yan J, Chen G, Gong J, et al. (2009). Upregulation of OX40–OX40 ligand system on T lymphocytes in patients with acute coronary syndromes. J Cardiovasc Pharmacol, 54(5), 451–455. doi:10.1097/FJC.0b013e3181be7578
   PubMed Web of Science ®Google Scholar
• Yoshioka T, Nakajima A, Akiba H, et al. (2000). Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis. Eur J Immunol, 30(10), 2815–2823. doi:10.1002/1521-4141(200010)30:10<2815::AID-IMMU2815>3.0.CO;2-#
   PubMed Web of Science ®Google Scholar